Design of a multiple drug delivery system directed at periodontitis

Biomaterials

Volumn 34, Issue 34, 2013, Pages 8835-8842

  Sundararaj, Sharath C ^a   Thomas, Mark V ^b   Peyyala, Rebecca ^b   Dziubla, Thomas D ^a   Puleo, David A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

Author keywords

Controlled drug release; Drug delivery; Drug release; Periodontium; Sequential drug release

Indexed keywords

ASSOCIATION POLYMERS; CELLULOSE ACETATE PHTHALATE; CHRONIC INFLAMMATORY; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG RELEASE; PERIODONTAL DISEASE; PERIODONTIUM;

CELLULOSE FILMS; DISEASE CONTROL; DRUG DELIVERY; DRUG PRODUCTS; POLYMER FILMS;

DISEASES;

ANTIBIOTIC AGENT; CELLACEFATE; DOXYCYCLINE; KETOPROFEN; METRONIDAZOLE; POLOXAMER; POLYMER; SIMVASTATIN;

ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; BONE REGENERATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; FILM; IN VITRO STUDY; INFLAMMATION; NONHUMAN; PATHOGENESIS; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; SLOW DRUG RELEASE; TISSUE INJURY;

CELLULOSE FILM; DISEASES;

BACTERIA (MICROORGANISMS);

CONTROLLED DRUG RELEASE; DRUG DELIVERY; DRUG RELEASE; PERIODONTIUM; SEQUENTIAL DRUG RELEASE;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CELLULOSE; DELAYED-ACTION PREPARATIONS; DOXYCYCLINE; DRUG DESIGN; HUMANS; KETOPROFEN; METRONIDAZOLE; MODELS, THEORETICAL; PERIODONTITIS; POLOXAMER; SIMVASTATIN;

EID: 84882928233     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.093     Document Type: Article

References (61)

1. Albandar J.M., Kingman A. Gingival recession, gingival bleeding, and dental calculus in adults 30 years of age and older in the United States, 1988-1994. JPeriodontol 1999, 70:30-43.
2. Brown L.J., Oliver R.C., Loe H. Periodontal diseases in the U.S. in 1981: prevalence, severity, extent, and role in tooth mortality. JPeriodontol 1989, 60:363-370.
3. Chen F.M., Jin Y. Periodontal tissue engineering and regeneration: current approaches and expanding opportunities. Tissue Eng Part B Rev 2010, 16:219-255.
4. Soskolne W.A., Klinger A. The relationship between periodontal diseases and diabetes: an overview. Ann Periodontol 2001, 6:91-98.
5. Rosen P.S. Treatment of plaque-induced gingivitis, chronic periodontitis, and other clinical conditions. JPeriodontol 2001, 72:1790-1800.
6. Etienne D. Locally delivered antimicrobials for the treatment of chronic periodontitis. Oral Dis 2003, 9(Suppl.1):45-50.
7. Polimeni G., Xiropaidis A.V., Wikesjö U.M.E. Biology and principles of periodontal wound healing/regeneration. Periodontology 2000, 2006(41):30-47.
8. Thomas M.V., Puleo D.A. Infection, inflammation, and bone regeneration: a paradoxical relationship. JDent Res 2011, 90:1052-1061.
9. Cochran D.L., Wennström J.L., Funakoshi E., Heijl L. Biomimetics in periodontal regeneration 2003, Quintessence Publishing Co, Inc, Hanover Park, IL.
10. Vyas S.P., Sihorkar V., Mishra V. Controlled and targeted drug delivery strategies towards intraperiodontal pocket diseases. JClin Pharm Ther 2000, 25:21-42.
11. Schwach-Abdellaoui K., Vivien-Castioni N., Gurny R. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm 2000, 50:83-99.
12. Srinivas M., Medaiah S., Girish S., Anil M., Pai J., Walvekar A. The effect of ketoprofen in chronic periodontitis: a clinical double-blind study. JInd Soc Periodontol 2011, 15:255-259.
13. Queiroz-Junior C.M., Pacheco C.M., Maltos K.L., Caliari M.V., Duarte I.D., Francischi J.N. Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats. JPeriodont Res 2009, 44:153-160.
14. Binderman I., Adut M., Yaffe A. Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats. JPeriodontol 2000, 71:1236-1240.
15. Seto H., Ohba H., Tokunaga K., Hama H., Horibe M., Nagata T. Topical administration of simvastatin recovers alveolar bone loss in rats. JPeriodont Res 2008, 43:261-267.
16. Yazawa H., Zimmermann B., Asami Y., Bernimoulin J.P. Simvastatin promotes cell metabolism, proliferation, and osteoblastic differentiation in human periodontal ligament cells. JPeriodontol 2005, 76:295-302.
17. King G.N., King N., Hughes F.J. Effect of two delivery systems for recombinant human bone morphogenetic protein-2 on periodontal regeneration invivo. JPeriodont Res 1998, 33:226-236.
18. Selvig K.A., Sorensen R.G., Wozney J.M., Wikesjo U.M. Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration. JPeriodontol 2002, 73:1020-1029.
19. Xu X., Lee P.I. Programmable drug delivery from an erodible association polymer system. Pharm Res 1993, 10:1144-1152.
20. Raiche A.T., Puleo D.A. Association polymers for modulated release of bioactive proteins. IEEE Eng Med Biol Mag 2003, 22:35-41.
21. Hopfenberg H.B. Controlled release from erodible slabs, cylinders, and spheres. Controlled release polymeric formulations 1976, 26-32. Americal Chemical Society, Washington, D.C.
22. Chen F.M., Zhang M., Wu Z.F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010, 31:6279-6308.
23. Santo V.E., Gomes M.E., Mano J.F., Reis R.L. Controlled release strategies for bone, cartilage, and osteochondral engineering-part II: challenges on the evolution from single to multiple bioactive factor delivery. Tissue Eng Part B Rev 2013, 19:327-352.
24. Simmons C.A., Alsberg E., Hsiong S., Kim W.J., Mooney D.J. Dual growth factor delivery and controlled scaffold degradation enhance invivo bone formation by transplanted bone marrow stromal cells. Bone 2004, 35:562-569.
25. Lynch S.E., de Castilla G.R., Williams R.C., Kiritsy C.P., Howell T.H., Reddy M.S., et al. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. JPeriodontol 1991, 62:458-467.
26. Chen F.M., Chen R., Wang X.J., Sun H.H., Wu Z.F. Invitro cellular responses to scaffolds containing two microencapulated growth factors. Biomaterials 2009, 30:5215-5224.
27. Patel Z.S., Young S., Tabata Y., Jansen J.A., Wong M.E., Mikos A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008, 43:931-940.
28. Peattie R.A., Rieke E.R., Hewett E.M., Fisher R.J., Shu X.Z., Prestwich G.D. Dual growth factor-induced angiogenesis invivo using hyaluronan hydrogel implants. Biomaterials 2006, 27:1868-1875.
29. Borselli C., Storrie H., Benesch-Lee F., Shvartsman D., Cezar C., Lichtman J.W., et al. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A 2010, 107:3287-3292.
30. Dogan A.K., Gumusderelioglu M., Aksoz E. Controlled release of EGF and bFGF from dextran hydrogels invitro and invivo. JBiomed Mater Res Part B Appl Biomater 2005, 74:504-510.
31. Buket Basmanav F., Kose G.T., Hasirci V. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 2008, 29:4195-4204.
32. Chen R.R., Silva E.A., Yuen W.W., Mooney D.J. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 2007, 24:258-264.
33. Jaklenec A., Hinckfuss A., Bilgen B., Ciombor D.M., Aaron R., Mathiowitz E. Sequential release of bioactive IGF-I and TGF-β from PLGA microsphere-based scaffolds. Biomaterials 2008, 29:1518-1525.
34. Kempen D.H., Lu L., Heijink A., Hefferan T.E., Creemers L.B., Maran A., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009, 30:2816-2825.
35. Tengood J.E., Kovach K.M., Vescovi P.E., Russell A.J., Little S.R. Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis. Biomaterials 2010, 31:7805-7812.
36. Gates K.A., Grad H., Birek P., Lee P.I. Anew bioerodible polymer insert for the controlled release of metronidazole. Pharm Res 1994, 11:1605-1609.
37. Jeon J.H., Puleo D.A. Alternating release of different bioactive molecules from a complexation polymer system. Biomaterials 2008, 29:3591-3598.
38. Sundararaj S.C., Thomas M.V., Dziubla T.D., Puleo D.A. Bioerodible system for sequential release of multiple drugs 2013, [in review].
39. Wright T.L., Ellen R.P., Lacroix J.M., Sinnadurai S., Mittelman M.W. Effects of metronidazole on Porphyromonas gingivalis biofilms. JPeriodont Res 1997, 32:473-477.
40. Japoni A., Vasin A., Noushadi S., Kiany F., Japoni S., Alborzi A. Antibacterial susceptibility patterns of Porphyromonas gingivalis isolated from chronic periodontitis patients. Med Oral Patol Oral Cir Bucal 2011, 16:e1031-e1035.
41. Tribble G.D., Lamont G.J., Progulske-Fox A., Lamont R.J. Conjugal transfer of chromosomal DNA contributes to genetic variation in the oral pathogen Porphyromonas gingivalis. JBacteriol 2007, 189:6382-6388.
42. Eick S., Pfister W. Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an invitro study. JPeriodontol 2004, 75:1327-1334.
43. Larsen T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol 2002, 17:267-271.
44. Sato S., Fonseca M.J., Ciampo J.O., Jabor J.R., Pedrazzi V. Metronidazole-containing gel for the treatment of periodontitis: an invivo evaluation. Braz Oral Res 2008, 22:145-150.
45. Tenenbaum H., Cuisinier F.J., Le Liboux A., Pichard E., Montay G., Frydman A. Secnidazole concentrations in plasma and crevicular fluid after a single oral dose. JClin Periodontol 1993, 20:505-508.
46. Van Oosten M.A., Notten F.J., Mikx F.H. Metronidazole concentrations in human plasma, saliva, and gingival crevice fluid after a single dose. JDent Res 1986, 65:1420-1423.
47. Williams R.C. Periodontal disease. NEngl J Med 1990, 322:373-382.
48. Paquette D.W., Fiorellini J.P., Martuscelli G., Oringer R.J., Howell T.H., McCullough J.R., et al. Enantiospecific inhibition of ligature-induced periodontitis in beagles with topical (S)-ketoprofen. JClin Periodontol 1997, 24:521-528.
49. Salvi G.E., Lang N.P. The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. Curr Pharm Des 2005, 11:1757-1769.
50. Paquette D.W., Lawrence H.P., McCombs G.B., Wilder R., Binder T.A., Troullos E., et al. Pharmacodynamic effects of ketoprofen on crevicular fluid prostanoids in adult periodontitis. JClin Periodontol 2000, 27:558-566.
51. Lawrence H.P., Paquette D.W., Smith P.C., Maynor G., Wilder R., Mann G.L., et al. Pharmacokinetic and safety evaluations of ketoprofen gels in subjects with adult periodontitis. JDent Res 1998, 77:1904-1912.
52. Vernillo A.T., Rifkin B.R. Effects of tetracyclines on bone metabolism. Adv Dent Res 1998, 12:56-62.
53. Llindhe J., Heijl L., Goodson J.M., Socransky S.S. Local tetracycline delivery using hollow fiber devices in periodontal therapy. JClin Periodontol 1979, 6:141-149.
54. Griffiths G.S., Ayob R., Guerrero A., Nibali L., Suvan J., Moles D.R., et al. Amoxicillin and metronidazole as an adjunctive treatment in generalized aggressive periodontitis at initial therapy or re-treatment: a randomized controlled clinical trial. JClin Periodontol 2011, 38:43-49.
55. Todd P.A., Goa K.L. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs 1990, 40:583-607.
56. Chen P.Y., Sun J.S., Tsuang Y.H., Chen M.H., Weng P.W., Lin F.H. Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway. Nutr Res 2010, 30:191-199.
57. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation invitro and in rodents by statins. Science 1999, 286:1946-1949.
58. Pradeep A.R., Thorat M.S. Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial. JPeriodontol 2010, 81:214-222.
59. Karring T., Nyman S., Gottlow J.A.N., Laurell L. Development of the biological concept of guided tissue regeneration: animal and human studies. Periodontology 2000, 1993(1):26-35.
60. Edwards C., Spector T. Statins as modulators of bone formation. Arthritis Res 2002, 4:151-153.
61. Jeon J.H., Piepgrass W.T., Lin Y.L., Thomas M.V., Puleo D.A. Localized intermittent delivery of simvastatin hydroxyacid stimulates bone formation in rats. JPeriodontol 2008, 79:1457-1464.